GE HealthCare Technologies (GEHC) Current Deferred Revenue (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Current Deferred Revenue came in at $3.1 billion in Q2 2026, up 12.39% YoY from $2.7 billion in Q2 2025, and up 2.86% on a QoQ basis from $3.0 billion in Q1 2026.
GE HealthCare Technologies (GEHC) Current Deferred Revenue (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Current Deferred Revenue data on file, last reported at $3.1 billion in Q2 2026.
- Quarterly Current Deferred Revenue rose 12.39% year-over-year to $3.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.1 billion (up 12.39% YoY) and the FY2025 annual result came in at $2.9 billion, up 10.27% from the prior year.
- Current Deferred Revenue improved to $3.1 billion in Q2 2026, from $3.0 billion in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $3.1 billion in Q2 2026 to a low of $2.5 billion in Q4 2022.
- A 5-year average of $2.7 billion and a median of $2.6 billion in 2024 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue dropped 4.29% — and 2026, when it climbed 13.74%.
- Tracing GEHC's Current Deferred Revenue over 5 years: stood at $2.5 billion in 2022, then rose by 3.84% to $2.6 billion in 2023, then rose by 0.23% to $2.6 billion in 2024, then grew by 10.27% to $2.9 billion in 2025, then grew by 5.45% to $3.1 billion in 2026.
- The last three Current Deferred Revenue figures came in at $3.1 billion (Q2 2026), $3.0 billion (Q1 2026), and $2.9 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.39 Bn | 18.98 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.06 Bn |
| Mar 31, 2026 | 2.97 Bn |
| Dec 31, 2025 | 2.90 Bn |
| Sep 30, 2025 | 2.78 Bn |
| Jun 30, 2025 | 2.72 Bn |
| Mar 31, 2025 | 2.61 Bn |
| Dec 31, 2024 | 2.63 Bn |
| Sep 30, 2024 | 2.62 Bn |
| Jun 30, 2024 | 2.56 Bn |
| Mar 31, 2024 | 2.57 Bn |
| Dec 31, 2023 | 2.62 Bn |
| Sep 30, 2023 | 2.61 Bn |
| Jun 30, 2023 | 2.67 Bn |
| Mar 31, 2023 | 2.68 Bn |
| Dec 31, 2022 | 2.53 Bn |